These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 14600276)

  • 61. Resveratrol induces catalytic bioscavenger paraoxonase 1 expression and protects against chemical warfare nerve agent toxicity in human cell lines.
    Curtin BF; Seetharam KI; Dhoieam P; Gordon RK; Doctor BP; Nambiar MP
    J Cell Biochem; 2008 Apr; 103(5):1524-35. PubMed ID: 17879943
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Effect of soman, sarin and VX on specific binding of 3H-quinuclidinyl benzilate in rat cerebral cortex homogenates].
    Zhao DL; Wang ZX; Pei SQ; Liu CH
    Zhongguo Yao Li Xue Bao; 1983 Dec; 4(4):225-8. PubMed ID: 6230862
    [No Abstract]   [Full Text] [Related]  

  • 63. Human serum butyrylcholinesterase: in vitro and in vivo stability, pharmacokinetics, and safety in mice.
    Saxena A; Sun W; Luo C; Doctor BP
    Chem Biol Interact; 2005 Dec; 157-158():199-203. PubMed ID: 16263104
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Butyrylcholinesterase, a stereospecific in vivo bioscavenger against nerve agent intoxication.
    Cerasoli DM; Armstrong SJ; Reeves TE; Hodgins SM; Kasten SA; Lee-Stubbs RB; Cadieux CL; Otto TC; Capacio BR; Lenz DE
    Biochem Pharmacol; 2020 Jan; 171():113670. PubMed ID: 31628910
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Biochemical and behavioral effects of soman vapors in low concentrations.
    Bajgar J; Sevelová L; Krejcová G; Fusek J; Vachek J; Kassa J; Herink J; de Jong LP; Benschop HP
    Inhal Toxicol; 2004 Jul; 16(8):497-507. PubMed ID: 15204741
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long-term effects of human butyrylcholinesterase pretreatment followed by acute soman challenge in cynomolgus monkeys.
    Sun W; Doctor BP; Lenz DE; Saxena A
    Chem Biol Interact; 2008 Sep; 175(1-3):428-30. PubMed ID: 18674756
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of reversible ligands on oxime-induced reactivation of sarin- and cyclosarin-inhibited human acetylcholinesterase.
    Scheffel C; Thiermann H; Worek F
    Toxicol Lett; 2015 Feb; 232(3):557-65. PubMed ID: 25522658
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
    Eckert S; Eyer P; Mückter H; Worek F
    Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy of structural homoloques and isomers of pralidoxime in reactivation of immobilised acetylcholinesterase inhibited with sarin, cyclosarin and soman.
    Hoskovcova M; Halamek E; Kobliha Z
    Neuro Endocrinol Lett; 2009; 30 Suppl 1():152-5. PubMed ID: 20027163
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase.
    Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A
    Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice.
    Ashani Y; Shapira S; Levy D; Wolfe AD; Doctor BP; Raveh L
    Biochem Pharmacol; 1991 Jan; 41(1):37-41. PubMed ID: 1986743
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?
    Aurbek N; Herkert NM; Koller M; Thiermann H; Worek F
    Chem Biol Interact; 2010 Sep; 187(1-3):215-9. PubMed ID: 20105433
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI 6 in vitro.
    Worek F; Aurbek N; Thiermann H
    J Appl Toxicol; 2007; 27(6):582-8. PubMed ID: 17370251
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
    Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
    Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacokinetics and efficacy of atropine sulfate/obidoxime chloride co-formulation against VX in a guinea pig model.
    Kentrop J; Savransky V; Klaassen SD; van Groningen T; Bohnert S; Cornelissen AS; Cochrane L; Barry J; Joosen MJA
    Regul Toxicol Pharmacol; 2021 Feb; 119():104823. PubMed ID: 33212192
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agents.
    Trovaslet-Leroy M; Musilova L; Renault F; Brazzolotto X; Misik J; Novotny L; Froment MT; Gillon E; Loiodice M; Verdier L; Masson P; Rochu D; Jun D; Nachon F
    Toxicol Lett; 2011 Sep; 206(1):14-23. PubMed ID: 21683774
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cholinesterases as scavengers for organophosphorus compounds: protection of primate performance against soman toxicity.
    Doctor BP; Blick DW; Caranto G; Castro CA; Gentry MK; Larrison R; Maxwell DM; Murphy MR; Schutz M; Waibel K
    Chem Biol Interact; 1993 Jun; 87(1-3):285-93. PubMed ID: 8343986
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ocular surface histopathological insult following sarin and VX exposure and potential treatments in the rat model.
    Gore A; Lazar S; Yacov G; Gez R; Rabinowitz I; Nili U; Egoz I; Kadar T
    Toxicol Lett; 2019 Oct; 314():153-163. PubMed ID: 31408696
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment with endotracheal therapeutics after sarin microinstillation inhalation exposure increases blood cholinesterase levels in guinea pigs.
    Che MM; Song J; Oguntayo S; Doctor BP; Rezk P; Perkins MW; Sciuto AM; Nambiar MP
    Toxicol Mech Methods; 2012 May; 22(4):250-9. PubMed ID: 22145985
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Potential of two new oximes in reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by organophosphate compounds: an in vitro study.
    Costa MD; Freitas ML; Soares FA; Carratu VS; Brandão R
    Toxicol In Vitro; 2011 Dec; 25(8):2120-3. PubMed ID: 21983245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.